Hansoh Pharmaceutical Group
$34.14Change from previous close: −3.29%Absolute change: −$1.16
At a glance
- Revenue growth
- +22.57%
- 2025 vs 2024
- Net income growth
- +27.07%
- 2025 vs 2024
- Net margin
- 37.0%
- 2024: 35.7%
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 39,900 | 31,658 | 33,039 | 30,002 | 27,160 |
| Current assets | 35,555 | 27,442 | 28,883 | 25,832 | 23,179 |
| Cash and equivalents | 31,549 | 22,622 | 22,435 | 17,615 | 14,702 |
| Short-term investments | 8.2 | 780 | 1,937 | 1,471 | 1,882 |
| Receivables | 3,246 | 3,264 | 3,295 | 3,626 | 3,729 |
| Inventory | 609 | 651 | 576 | 448 | 410 |
| Net property, plant and equipment | 3,179 | 3,247 | 3,280 | 3,450 | 3,475 |
| Other intangible assets | 363 | 245 | 177 | 33.4 | 17.0 |
| Long-term investments | 772 | 702 | 685 | 654 | 395 |
| Current liabilities | 4,395 | 2,695 | 6,863 | 2,620 | 3,024 |
| Accounts payable | 334 | 218 | 164 | 222 | 248 |
| Long-term debt | — | 0.0 | 39.7 | 4,283 | 3,743 |
| Total debt | 105 | 118 | 4,304 | 4,378 | — |
| Total liabilities | 4,536 | 2,978 | 7,244 | 7,355 | 7,131 |
| Total equity (incl. minority) | 35,364 | 28,680 | 25,795 | 22,647 | 20,029 |
| Retained earnings | 17,461 | 13,918 | 11,405 | 8,780 | 6,910 |
| Minority interest | — | — | 0.0 | 0.0 | 0.0 |